JPMorgan Upgrades Corteva to Overweight with 40% Upside Potential

JPMorgan Chase & Co. has upgraded Corteva (NYSE: CTVA) from a "neutral" to an "overweight" rating, assigning a price target of $19.00. This target suggests a potential upside of 39.65% from the stock's current price of $13.61. The upgrade comes as several other analysts have also weighed in on the agricultural company, with mixed outlooks.

Bank of America raised its price target to $96.00 with a "buy" rating, while Royal Bank of Canada maintained an "outperform" rating with a $103.00 target. Conversely, Weiss Ratings downgraded Corteva to a "hold (c)" rating. Citigroup increased its target to $91.00 but kept a "neutral" rating. Oppenheimer set a $17.00 price objective. Currently, 15 analysts rate the stock as a "buy" and eight as a "hold," resulting in a consensus "moderate buy" rating and a target price of $73.95.

Corteva's stock saw a 9.8% increase on Tuesday, closing at $13.61 with a trading volume of 10.68 million shares. The company has a 52-week range of $11.74 to $90.97. Its financials include a market capitalization of $9.08 billion, a PE ratio of 9.01, and a debt-to-equity ratio of 0.07. The company reported quarterly earnings of $2.30 per share, beating estimates by $0.06, but revenue declined 1.2% year-over-year.

Several institutional investors have adjusted their stakes in Corteva, including MassMutual Private Wealth & Trust FSB, which increased its holdings by 200.2%. Other investors like QRG Capital Management, Envestnet Portfolio Solutions, and Reynders McVeigh Capital Management also boosted their positions. Institutional investors now own 81.54% of the company's stock.